Six month immunogenicity of COVID-19 mRNA-BNT162b2 vaccine in actively treated cancer patients: updated results of the Vax-On study

Detalles Bibliográficos
Autores principales: Nelli, F., Fabbri, A., Onorato, A., Giannarelli, D., Silvestri, M.A., Pessina, G., Giron Berrios, J.R., Virtuoso, A., Marrucci, E., Schirripa, M., Mazzotta, M., Panichi, V., Cercola, P., Signorelli, C., Chilelli, M.G., Primi, F., Ruggeri, E.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660134/
https://www.ncbi.nlm.nih.gov/pubmed/34896598
http://dx.doi.org/10.1016/j.annonc.2021.12.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660134/
https://www.ncbi.nlm.nih.gov/pubmed/34896598
http://dx.doi.org/10.1016/j.annonc.2021.12.001

Ejemplares similares